Skip to main content
Neuland Laboratories Limited. logo

Neuland Laboratories Limited. — Investor Relations & Filings

Ticker · NEULANDLAB ISIN · INE794A01010 LEI · 335800AVHZURTYQ17N08 BSE.NS Manufacturing
Open in API
Filings indexed 945 across all filing types
Latest filing 2024-07-01 Capital/Financing Update
Country IN India
Listing BSE.NS NEULANDLAB

About Neuland Laboratories Limited.

https://www.neulandlabs.com

Neuland Laboratories Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and provides comprehensive Custom Manufacturing Solutions (CMS). The company focuses on complex chemistry and high-quality standards, operating state-of-the-art manufacturing facilities that comply with international regulatory requirements, including those of the USFDA and EDQM. Its product portfolio spans diverse therapeutic areas such as cardiovascular, central nervous system, anti-infectives, and antiasthmatics. Neuland supports pharmaceutical companies globally through the entire lifecycle of a drug, from early-stage clinical development to commercial-scale production. By leveraging advanced technical expertise and a robust quality management system, the organization delivers reliable chemical synthesis and process optimization services to both innovator and generic drug manufacturers.

Recent filings

Filing Released Lang Actions
Updates
Capital/Financing Update Classification · 95% confidence The document is a letter addressed to stock exchanges providing an update on the transfer of part of a company property. It references a previous board approval and informs about a transaction (transfer by perpetual lease) with a financial consideration amount. The document is short (1262 characters) and serves as an announcement of a specific transaction or capital asset update. It does not contain financial statements, audit information, or detailed financial results. It is not a report or a certification. The content fits best under Capital/Financing Update (CAP) as it relates to a financing or capital asset transaction update.
2024-07-01 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges notifying the closure of the trading window pursuant to the company's Insider Trading Code. It mentions the upcoming declaration of financial results for the quarter ended June 30, 2024, but does not contain any financial data or results itself. The document is short (1143 characters) and serves as an announcement related to trading restrictions ahead of financial results disclosure. It does not qualify as an Interim/Quarterly Report (IR) or Earnings Release (ER) because it lacks substantive financial information. It is also not a report publication announcement since it does not mention the release or availability of a report. The content fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance-related notices that do not fit other categories.
2024-06-26 English
Copy of Newspaper Publication
AGM Information Classification · 95% confidence The document is a detailed communication addressed to stock exchanges regarding a newspaper advertisement about the 40th Annual General Meeting (AGM) of Neuland Laboratories Limited. It references Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates disclosure of such advertisements. The content includes information about the AGM date, mode (Video Conferencing/Other Audio Visual Means), record date, and related procedural details. It also mentions the availability of the Notice of AGM and the Integrated Annual Report on the company's website and stock exchange websites. The document is not the AGM materials themselves but an announcement of the AGM and related information through a newspaper advertisement. It does not contain financial statements or detailed financial analysis, nor is it a transcript or management discussion. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or related announcements about the AGM event.
2024-06-21 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the issuance of a Letter of Confirmation in lieu of lost/misplaced share certificates. It references SEBI regulations and provides details of the shareholder and shares involved. The content is an official notification about share certificate replacement, not a financial report, earnings release, or management discussion. The document length is short (1368 characters) and it serves as an announcement or regulatory communication. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-06-21 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about the schedule of analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is an announcement of upcoming investor meetings, not a financial report, earnings release, or detailed presentation. The document length is only 1277 characters, indicating it is a brief announcement rather than a detailed report. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2024-06-18 English
Updates
Regulatory Filings Classification · 95% confidence The document is a press release announcing a change in the company's logo and brand identity. It is addressed to stock exchanges and references compliance with SEBI Listing Regulations. The content focuses on branding and corporate identity rather than financial performance, management changes, or regulatory filings. The document length is 3969 characters, which is relatively short and does not contain financial data or detailed report content. It is not an announcement of voting results, management changes, or financial results. It is a corporate communication about branding, which does not fit into categories like Annual Report, Earnings Release, or Management Reports. The closest fitting category is Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2024-06-10 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.